Literature DB >> 27625029

A Novel Mutation in Helical Domain 2 of NOD2 in Sporadic Blau Syndrome.

Lubhani Jain1, Namrata Gupta1, Mamatha M Reddy2, Ruchi Mittal3, Manas Ranjan Barik2, Bharat Panigrahi4, Tom Monie5, Soumyava Basu1.   

Abstract

We report a 12-year-old girl who presented with bilateral granulomatous anterior uveitis accompanied by boggy arthritis of knee and ankle joints, intermittent fever, and nodular skin rash. She was diagnosed with sporadic Blau syndrome (early-onset sarcoidosis) based on above clinical signs and presence of non-necrotising granuloma on iris biopsy. DNA sequencing revealed a previously unreported heterozygous mutation consisting of a G>A transition in exon 4 of the NOD2 gene. This resulted in a glutamic acid to lysine substitution in helical domain 2 of the nucleotide binding and oligomerization (NACHT) region, possibly reducing efficiency of auto-inhibition in NOD2 signaling. Interestingly, the ocular inflammation resolved completely following therapeutic vitrectomy in both eyes whereas the systemic symptoms of fever and arthritis continued to wax and wane while on treatment with oral methotrexate and corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27625029      PMCID: PMC5849224          DOI: 10.1080/09273948.2016.1207789

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  6 in total

1.  Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases.

Authors:  Mathias Chamaillard; Dana Philpott; Stephen E Girardin; Habib Zouali; Suzanne Lesage; Fabrice Chareyre; The Hung Bui; Marco Giovannini; Ulrich Zaehringer; Virginie Penard-Lacronique; Philippe J Sansonetti; Jean-Pierre Hugot; Gilles Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

2.  Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.

Authors:  Jae Dugan; Eric Griffiths; Paige Snow; Holly Rosenzweig; Ellen Lee; Brieanna Brown; Daniel W Carr; Carlos Rose; James Rosenbaum; Michael P Davey
Journal:  J Immunol       Date:  2014-11-26       Impact factor: 5.422

3.  Pediatric granulomatous arthritis: an international registry.

Authors:  Carlos D Rosé; Carine H Wouters; Silvia Meiorin; Trudy M Doyle; Michael P Davey; James T Rosenbaum; Tammy M Martin
Journal:  Arthritis Rheum       Date:  2006-10

4.  Familial granulomatous arthritis, iritis, and rash.

Authors:  E B Blau
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

5.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.

Authors:  Nobuo Kanazawa; Ikuo Okafuji; Naotomo Kambe; Ryuta Nishikomori; Mami Nakata-Hizume; Sonoko Nagai; Akihiko Fuji; Takenosuke Yuasa; Akira Manki; Yoshihiko Sakurai; Mitsuru Nakajima; Hiroko Kobayashi; Ikuma Fujiwara; Hiroyuki Tsutsumi; Atsushi Utani; Chikako Nishigori; Toshio Heike; Tatsutoshi Nakahata; Yoshiki Miyachi
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

6.  Familial granulomatous synovitis, uveitis, and cranial neuropathies.

Authors:  D A Jabs; J L Houk; W B Bias; F C Arnett
Journal:  Am J Med       Date:  1985-05       Impact factor: 4.965

  6 in total
  4 in total

Review 1.  NOD1 and NOD2 in inflammatory and infectious diseases.

Authors:  Bruno C Trindade; Grace Y Chen
Journal:  Immunol Rev       Date:  2020-07-17       Impact factor: 12.988

Review 2.  Early diagnosis of early-onset sarcoidosis: a case report with functional analysis and review of the literature.

Authors:  Yusuke Takeuchi; Tomonari Shigemura; Norimoto Kobayashi; Naoe Kaneko; Tomoyuki Iwasaki; Kisei Minami; Keiko Kobayashi; Junya Masumoto; Kazunaga Agematsu
Journal:  Clin Rheumatol       Date:  2017-01-27       Impact factor: 3.650

3.  Blau syndrome: An under-reported condition in India?

Authors:  A Agarwal; S Karande
Journal:  J Postgrad Med       Date:  2022 Apr-Jun       Impact factor: 1.566

4.  Uveitis in sporadic Blau syndrome: Long-term follow-up of a refractory case treated successfully with adalimumab.

Authors:  Anmol U Naik; Radha Annamalai; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2018-10       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.